TY - CHAP M1 - Book, Section TI - Pharmacotherapy of the Epilepsies A1 - Metcalf, Cameron S. A1 - Smith, Misty D. A1 - Wilcox, Karen S. A2 - Brunton, Laurence L. A2 - Knollmann, Björn C. PY - 2023 T2 - Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 14th Edition AB - The epilepsies are common and frequently devastating disorders, affecting approximately 2.5 million people in the U.S. alone. More than 40 distinct forms of epilepsy have been identified. Epileptic seizures often cause transient impairment of awareness, leaving the individual at risk of bodily harm and often interfering with education and employment. Current therapy is symptomatic, as available antiseizure drugs (ASDs) inhibit seizures, but neither effective prophylaxis nor cure is available. Adherence to prescribed treatment regimens is a major problem because of the need for long-term therapy together with unwanted effects of many drugs. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accessanesthesiology.mhmedical.com/content.aspx?aid=1193230050 ER -